Industry
Biotechnology
Topic
Event Announcements
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Event Announcements in Biotechnology
... PRESS RELEASE December 12, 2017 Saniona, a leading biotech company in the field of ion channels, today announced ...
... CAMBRIDGE, Mass. - Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development ...
... SAN DIEGO - Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the BMO Capital Markets 2017 Prescriptions for ...
... CAMBRIDGE, Mass., Dec. 10, 2017 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company developing novel epigenetic therapies, today announced that ...
... ATLANTA, Dec. 09, 2017 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers ...
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the BMO Capital Markets 2017 Prescriptions for ...
... Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Guggenheim 5th ...
... Saskatoon, SK, Canada. In the presentation, Dr. Snell will highlight the approach Yield10 and its wholly owned Canadian subsidiary, Metabolix Oilseeds, are taking to increase ...
... CAMBRIDGE, Mass., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical stage company focused on the discovery and development ...
... SOUTH SAN FRANCISCO, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein ...
... SEATTLE, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology ...
... Intrexon Corporation(NYSE: XON), a leader in the engineering and industrialization of biology to improve ...
... Tocagen Inc.(Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced that Marty Duvall, ...
... Alkahest Inc. ("Alkahest"), a clinical-stage biotechnology company focused on developing innovative therapies to treat ...
... of cancer and graft-versus-host-disease. The Company's immuno-oncology programs, in collaboration with Intrexon Corporation (NYSE:XON) and the MD Anderson Cancer Center, include chimeric antigen receptor T ...
... YONKERS, N.Y., Nov. 10, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein ...
... Symic Bio, a biopharmaceutical company developing novel matrix-targeting biotherapeutics, today announced that Ken ...
... equals or exceeds $3.00. Medical Marijuana, Inc.(OTC: MJNA) announced yesterday that subsidiary Kannaway, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical ...
... industry include: Reliq Health Technologies Inc. (OTC: RQHTF) (TSX-V: RHT), Sangamo Therapeutics, Inc. (NASDAQ: SGMO), Editas Medicine, Inc. (NASDAQ: EDIT), Tenet Healthcare Corporation (NYSE: THC), ...
... Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of ...
... PureTech Health plc (LSE: PRTC), an advanced, clinical-stage biopharmaceutical company, today announced that Eric Elenko, ...
... TEL AVIV, Israel, Nov. 09, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization ...
... UTRECHT, The Netherlands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced ...
... our unique business model and capabilities." Mr. Sharma continued, "Our acquisition of vivoPharm is an excellent example of our commitment as we seek to broaden ...
... CAMBRIDGE, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that ...
... JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and ...
... LEXINGTON, Mass. - Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of ...
Want to see the full history of news? Upgrade to RelSci Professional now!
Start My Free Trial